title: Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration.
authors.forename: T M
authors.initials: TM
authors.lastname: De Pas
authors.forename: F
authors.initials: F
authors.lastname: Toffalorio
authors.forename: C
authors.initials: C
authors.lastname: Catania
authors.forename: C
authors.initials: C
authors.lastname: Noberasco
authors.forename: G
authors.initials: G
authors.lastname: Spitaleri
authors.forename: L
authors.initials: L
authors.lastname: Spaggiari
authors.forename: F
authors.initials: F
authors.lastname: De Braud
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D004357:Drug Synergism; D005971:Glutamates / Q000008:administration & dosage; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D000068437:Pemetrexed; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D005971:Glutamates; D000068437:Pemetrexed; D003841:Deoxycytidine; D006147:Guanine; D000093542:Gemcitabine